These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29169757)

  • 1. Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study.
    Jansen H; Jänsch A; Breitling LP; Hoppe L; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
    Int J Cardiol; 2018 Jan; 250():247-252. PubMed ID: 29169757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study.
    Jansen H; Jaensch A; Schöttker B; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
    J Am Heart Assoc; 2019 Jun; 8(12):e011882. PubMed ID: 31189389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
    Jansen H; Koenig W; Jaensch A; Mons U; Breitling LP; Scharnagl H; Stojakovic T; Schunkert H; Brenner H; Rothenbacher D
    Clin Chem; 2016 Oct; 62(10):1372-9. PubMed ID: 27540030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.
    Koenig W; Breitling LP; Hahmann H; Wüsten B; Brenner H; Rothenbacher D
    Clin Chem; 2012 Aug; 58(8):1215-24. PubMed ID: 22634379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
    Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and Joint Associations of High-Sensitivity Troponin I and High-Sensitivity Troponin T with Cardiac Phenotypes and Outcomes in the General Population: An Analysis From the Dallas Heart Study.
    Vigen R; Ayers C; Berry J; Rohatgi A; Nambi V; Ballantyne CM; Omland T; de Filippi CR; de Lemos J
    J Am Heart Assoc; 2024 Jul; 13(13):e034549. PubMed ID: 38842289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal plane T-wave axis orientation predicts coronary events: Findings from the Moli-sani study.
    Iacoviello L; Bonaccio M; Di Castelnuovo A; Costanzo S; Rago L; De Curtis A; Assanelli D; Badilini F; Vaglio M; Persichillo M; Macfarlane PW; Cerletti C; Donati MB; de Gaetano G;
    Atherosclerosis; 2017 Sep; 264():51-57. PubMed ID: 28772106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents.
    Cardinaels EP; Daamen MA; Bekers O; ten Kate J; Niens M; van Suijlen JD; van Dieijen-Visser MP; Brunner-La Rocca HP; Schols JM; Mingels AM
    J Am Med Dir Assoc; 2015 Oct; 16(10):884-91. PubMed ID: 26255708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.
    Dallmeier D; Denkinger M; Peter R; Rapp K; Jaffe AS; Koenig W; Rothenbacher D;
    Clin Chem; 2015 Feb; 61(2):389-99. PubMed ID: 25501933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Troponins: Contemporary Biological Data and New Methods of Determination.
    Chaulin A
    Vasc Health Risk Manag; 2021; 17():299-316. PubMed ID: 34113117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Troponin T and Troponin I in the General Population.
    Welsh P; Preiss D; Hayward C; Shah ASV; McAllister D; Briggs A; Boachie C; McConnachie A; Padmanabhan S; Welsh C; Woodward M; Campbell A; Porteous D; Mills NL; Sattar N
    Circulation; 2019 Jun; 139(24):2754-2764. PubMed ID: 31014085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
    Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
    Bargnoux AS; Kuster N; Patrier L; Dupuy AM; Tachon G; Maurice F; Badaoui B; Chalabi L; Badiou S; Deleuze S; Leray-Moragues H; Morena M; Canaud B; Cristol JP
    Clin Chem Lab Med; 2016 Apr; 54(4):673-82. PubMed ID: 26457775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study.
    Pohlhammer J; Kronenberg F; Rantner B; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kollerits B
    Atherosclerosis; 2014 Dec; 237(2):711-7. PubMed ID: 25463110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Zhu K; Knuiman M; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Hung J
    Heart; 2018 Jun; 104(11):895-903. PubMed ID: 29066610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention.
    Laugaudin G; Kuster N; Petiton A; Leclercq F; Gervasoni R; Macia JC; Cung TT; Dupuy AM; Solecki K; Lattuca B; Cade S; Cransac F; Cristol JP; Roubille F
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):354-63. PubMed ID: 25943557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction.
    Solecki K; Dupuy AM; Kuster N; Leclercq F; Gervasoni R; Macia JC; Cung TT; Lattuca B; Cransac F; Cade S; Pasquié JL; Cristol JP; Roubille F
    Clin Chem Lab Med; 2015 Apr; 53(5):707-14. PubMed ID: 25381953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
    de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
    Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.